Funding awarded
- Discovery of first-in-class small molecule TREM2 ligands as therapeutics for Alzheimer''s disease awarded by National Institute on Aging Key Personnel 2024 - 2029
- Small molecule inhibitors of CAPON-induced tau aggregation awarded by National Institute on Aging Key Personnel 2024 - 2027
- missing activity Key Personnel 2023 - 2024